Valuation: Novartis AG

Market Cap 308B 277B 253B 231B 435B 28,987B 448B 3,047B 1,215B 15,467B 1,157B 1,133B 48,828B P/E 2026 *
23.5x
P/E 2027 * 19.1x
Enterprise Value 343B 308B 281B 257B 483B 32,236B 499B 3,388B 1,351B 17,200B 1,287B 1,260B 54,300B EV / Sales 2026 *
5.98x
EV / Sales 2027 * 5.48x
Free-Float
91.66%
Yield 2026 *
2.65%
Yield 2027 * 2.79%
1 day-0.98%
1 week+0.59%
Current month-0.52%
1 month+14.25%
3 months+6.93%
6 months+17.21%
Current year+21.42%
1 week 130.1
Extreme 130.1
135.22
1 month 117.26
Extreme 117.26
135.22
Current year 107.68
Extreme 107.68
135.22
1 year 99.45
Extreme 99.45
135.22
3 years 81.1
Extreme 81.1
135.22
5 years 72.84
Extreme 72.84
135.22
10 years 65.09
Extreme 65.09
135.22
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%+0.59%+31.01%+59.68% 311B
-0.79%-4.48%+44.44%+127.49% 1,216B
+1.43%+1.11%+47.73%+82.08% 656B
+1.07%-1.21%+32.99%+106.31% 509B
-0.36%-2.84%+47.23%+64.51% 384B
-0.14%-1.87%+71.05%+40.63% 362B
-0.80%+6.73%+11.89%+35.64% 293B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 208B
-0.66%+3.50%-10.50%-60.60% 180B
Average -0.20%+0.96%+35.70%+63.02% 436.74B
Weighted average by Cap. -0.14%+0.21%+40.29%+82.35%

Financials

2026 *2027 *
Net sales 57.38B 51.47B 47.04B 42.94B 80.9B 5,394B 83.45B 567B 226B 2,878B 215B 211B 9,086B 61.5B 55.16B 50.41B 46.02B 86.7B 5,781B 89.44B 608B 242B 3,085B 231B 226B 9,738B
Net income 13.58B 12.18B 11.13B 10.16B 19.15B 1,277B 19.75B 134B 53.51B 681B 50.98B 49.89B 2,151B 15.99B 14.34B 13.11B 11.97B 22.55B 1,503B 23.26B 158B 63.01B 802B 60.03B 58.74B 2,532B
Net Debt 34.56B 30.99B 28.33B 25.86B 48.72B 3,249B 50.25B 341B 136B 1,733B 130B 127B 5,472B 28.54B 25.6B 23.39B 21.35B 40.23B 2,683B 41.5B 282B 112B 1,431B 107B 105B 4,519B
Projected Income Statement - Annual - Novartis AG
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
06/11/26 CHF 133.08 -0.78% 4,011,966
05/11/26 CHF 134.12 -0.10% 5,037,076
04/11/26 CHF 134.26 +2.10% 3,843,495
03/11/26 CHF 131.50 -0.02% 2,849,340
02/11/26 CHF 131.52 -1.69% 3,325,268
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Novartis AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
164.55USD
Average target price
151.24USD
Spread / Average Target
-8.09%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Novartis AG
  1. Stock Market
  2. Stocks
  3. NOVN Stock